ATXA Therapeutics

Innovation

Dublin · Founded 2015 · $2.9M raised

Headquarters
Dublin
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$2.9M
Last Round
$2.9M GrantOct 2018
Rounds
2

About

ATXA Therapeutics is a Dublin, Ireland-based clinical-stage pharmaceutical company developing novel small-molecule antagonists of the Thromboxane Receptor (TP) for cardiopulmonary diseases. Founded in 2015 by Professor Therese Kinsella as a University College Dublin spin-out, its lead compound NTP42 is in development for pulmonary arterial hypertension and has received Orphan Drug Designation from both the EMA and FDA.

Summary

ATXA Therapeutics is a Biotech company based in Dublin, founded in 2015. It has raised $2.9M in total across 2 rounds, most recently a $2.9M Grant round in Oct 2018. Investors include European Innovation Council Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantOct 2018

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ATXA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/atxa-therapeutics"><img src="https://indexed.vc/api/badge/company/atxa-therapeutics" alt="ATXA Therapeutics on Indexed.vc" width="260" height="76" /></a>